Frequent Antiviral Treatment Failures in Patients Infected With Hepatitis C Virus Genotype 4, Subtype 4r-Reference-Cited by-同舟云学术

Frequent Antiviral Treatment Failures in Patients Infected With Hepatitis C Virus Genotype 4, Subtype 4r

Published:2019-01-05 Issue:2 Volume:69 Page:513-523
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Fourati Slim¹²,Rodriguez Christophe¹²,Hézode Christophe²³,Soulier Alexandre¹²,Ruiz Isaac²³,Poiteau Lila¹²,Chevaliez Stéphane¹²,Pawlotsky Jean‐Michel¹²

Affiliation:

1. National Reference Center for Viral Hepatitis B, C and D Department of Virology Henri Mondor Hospital, University of Paris‐Est Créteil France

2. INSERM U955 Créteil France

3. Department of Hepatology Henri Mondor Hospital, University of Paris‐Est Créteil France

Funder

National Agency for Research on AIDS and Viral Hepatitis

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30225

Reference35 articles.

1. EASL Recommendations on Treatment of Hepatitis C 2018

2. Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes

3. The American Association for the Study of Liver Diseases and the Infectious Diseases Society of America.HCV Guidance: Recommendations for Testing Managing and Treating Hepatitis C. May 24 2018.https://www.hcvguidelines.org/.

4. All-oral direct-acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV-coinfected subjects in real-world practice: Madrid coinfection registry findings

5. Real-world use, effectiveness and safety of anti-viral treatment in chronic hepatitis C genotype 3 infection

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients;JHEP Reports;2024-07

2. Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis;Swiss Medical Weekly;2024-06-24

3. ‘Unusual’ HCV genotype subtypes: origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatment;Gut;2024-05-23

4. Metagenomics- Paving the Path for Sustainable Circular Bioeconomy;Circular Economy and Sustainability;2024-05-23

5. A Systematic Review on the Evolution of Natural Mutation-dependent Antiviral Drug Resistance in Hepatitis C Virus (HCV) Genotypes Prevalent in Saudi Arabia: A Genomic and Therapeutic Perspective;The Natural Products Journal;2024-04-03